| Developers: | SynCardia |
| Date of the premiere of the system: | November 2024 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
Content |
History
2024: Product Announcement
In early November 2024, the American company SynCardia announced a technology for a fully implantable artificial heart called Emperor.
Earlier in March 2024, SynCardia already received the first patent (No. 11.918.797) for the use of a fully implantable artificial heart. The United States Patent and Mercantile Office (USPTO) later issued a second and patent (No. 12.121.711 B2). Both patents describe a technology without the use of external drive mechanisms that allows full integration of the pumping mechanism into the implanted artificial ventricle of the heart.
SynCardia Develops 50 and 70 cc Artificial Heart Implants See Chief Operating Officer and technology inventor Matt Schuster said in a news release that fully implantable heart implants in development are consistent with or even superior in function to conventional transplantable hearts. However, the energy needs of the implant are comparable to those of the human heart.
The Emperor implant is a "balanced system that pulsates like a real heart," Schuster said. The implant uses a technology to displace fluid in a given volume upon contact with blood and eliminates the need for an external pneumatic actuator. It is assumed that such an artificial heart will completely change the approach to treating patients waiting for a heart transplant.
 | Our clinical experience covers more than 2,000 heart failure patients who have had their current artificial heart model implanted. The Emperor implant is expected to be the world's first fully implantable artificial heart and an effective alternative to heart transplantation, "said Patrick N. J. Schnegelsberg, CEO of the company.[1] |  |
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |